FDA Inspection 810072 — Mary Bird Perkins Cancer Center

Mary Bird Perkins Cancer Center — FEI 3005551893

The FDA completed an inspection of Mary Bird Perkins Cancer Center on November 8, 2012 in Hammond, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 8, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Hammond, LA (United States)